Denis Drygin

Chief Scientific Officer, Regulus Therapeutics Inc.

Companies

Regulus Therapeutics Inc.Chief Scientific Officer Aug 4, 2020 to Mar 1, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Regulus Therapeutics Inc.100,000 shares²Mar 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2022Bought 76,686 shares at $0.23 of Regulus Therapeutics Inc.²
Feb 4, 2022Bought 23,314 shares at $0.23 of Regulus Therapeutics Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRegulus Therapeutics Inc., Chief Scientific Officer
2
SEC EDGARRegulus Therapeutics Inc. shares after the filing of Mar 1, 2022
3
SEC EDGARForm 4 filed Feb 7, 2022